Keyphrases
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
100%
Cancer Therapy
100%
Species Selectivity
100%
Urokinase-type Plasminogen Activator
100%
Urokinase
100%
General Inhibitor
20%
Species Barrier
20%
Tumor Model
20%
Fibrinolysis
20%
Surface Plasmon Resonance
20%
Activity Control
20%
Plasmin Activity
20%
Cell Surface
20%
Across Species
20%
Functional Studies
20%
Rational Design
20%
High-affinity Interaction
20%
Intervention Studies
20%
Glycolipids
20%
Mouse Model
20%
Wound Healing
20%
Pathological Conditions
20%
Orthologs
20%
Plasminogen Activation
20%
Pharmacology, Toxicology and Pharmaceutical Science
Urokinase
100%
Malignant Neoplasm
100%
Receptor
100%
Tumor Model
16%
Intervention Study
16%
Plasmin
16%
Murine
16%
Mouse Model
16%
Surface Plasmon Resonance
16%
Wound Healing
16%
Glycolipid
16%
Plasminogen
16%
Biochemistry, Genetics and Molecular Biology
Urokinase
100%
Fibrinolysin
16%
Wound Healing
16%
Surface Plasmon Resonance
16%
Glycolipid
16%
Orthology
16%
Fibrinolysis
16%
Plasmin
16%
Murine
16%
Plasminogen Activation
16%
Mouse Model
16%
Crystal Structure
16%
Intervention Study
16%